Discontinuation Notice: Flovent HFA and Flovent Diskus
On December 31, 2023, GSK will discontinue all strengths of Flovent HFA and Flovent Diskus.…
Blood Cancer Drug Fails Main Goal of Trial
GlaxoSmithKline (GSK) recently announced that their blood cancer drug Blenrep failed the main goal…